More on TENX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $1.78 |
|
|||
| Open | $1.82 | ||||
| 52 Wk High | $3.40 | ||||
| 52 Wk Low | $1.34 | ||||
| Day High | $1.96 | ||||
| Day Low | $1.80 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 4,542,531 | ||||
- Guggenheim Downgrades Tenax Therapeutics (TENX) to Neutral
- Tenax shares Phase 3 LEVEL trial data at ESC Congress 2026
- Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026
- Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: ING GROEP NV
- Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: SPHERA FUNDS MANAGEMENT LTD.
- Form 4 TENAX THERAPEUTICS, INC. For: Aug 20 Filed by: Schneeberger Daniel
- Form 3 TENAX THERAPEUTICS, INC. For: Aug 20 Filed by: Schneeberger Daniel
- Form SCHEDULE 13G TENAX THERAPEUTICS, INC. Filed by: MILLENNIUM MANAGEMENT LLC
- Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: Ikarian Capital, LLC
- Form SCHEDULE 13G/A TENAX THERAPEUTICS, INC. Filed by: PERCEPTIVE ADVISORS LLC
Entities mentioned with TENX
- 13G | View Related Stories »
- FDA | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- S1 | View Related Stories »
- Guggenheim | View Related Stories »
- Show More...
